Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An autosomal dominant inherited adenocarcinoma that arises from the gastric mucosa and is characterized by the presence of poorly cohesive malignant cells and absence of glandular formations.
Biomarker and diagnostic research for hereditary diffuse gastric adenocarcinoma has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
258 publications have been identified in PubMed for hereditary diffuse gastric adenocarcinoma. Kisho has analyzed 156 by research type. Research spans Review / Meta-Analysis (36%), Basic Science / Preclinical (17%), and Diagnostic / Biomarker (15%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 56 |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 3:03 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research | 27 | 17% |
Testing and diagnosis research | 23 | 15% |
Disease patterns and progression | 16 | 10% |
Clinical study results | 12 | 8% |
Patient case studies | 9 | 6% |
New treatment approaches | 9 | 6% |
Other research | 4 | 3% |
Michelon I (2026). [PMID: 41517847](https://pubmed.ncbi.nlm.nih.gov/41517847/). *Journal of gastric cancer*. [Epidemiology / Natural History]
Wang N (2026). [PMID: 41837312](https://pubmed.ncbi.nlm.nih.gov/41837312/). *J Cancer Res Ther*. [Review / Meta-Analysis]
Zhao Q (2026). [PMID: 41720086](https://pubmed.ncbi.nlm.nih.gov/41720086/). *Cancer Cell*. [Basic Science / Preclinical]
Nagaraju GP (2026). [PMID: 41687726](https://pubmed.ncbi.nlm.nih.gov/41687726/). *Pharmacol Res*. [Review / Meta-Analysis]
Maurya P (2026). [PMID: 41809457](https://pubmed.ncbi.nlm.nih.gov/41809457/). *World journal of gastroenterology*. [Diagnostic / Biomarker]
Vijayvergia N (2026). [PMID: 41236448](https://pubmed.ncbi.nlm.nih.gov/41236448/). *Gastroenterology*. [Review / Meta-Analysis]
Lee H (2026). [PMID: 41297892](https://pubmed.ncbi.nlm.nih.gov/41297892/). *Zentralblatt fur Chirurgie*. [Diagnostic / Biomarker]
Ooki A (2025). [PMID: 40437298](https://pubmed.ncbi.nlm.nih.gov/40437298/). *Cancer Metastasis Rev*. [Review / Meta-Analysis]
Shan Z (2025). [PMID: 40977684](https://pubmed.ncbi.nlm.nih.gov/40977684/). *Frontiers in immunology*. [Case Report / Case Series]
Balmaceda NB (2025). [PMID: 39832053](https://pubmed.ncbi.nlm.nih.gov/39832053/). *Curr Oncol Rep*. [Review / Meta-Analysis]
AI-curated news mentioning hereditary diffuse gastric adenocarcinoma
Updated Aug 29, 2026
A case report highlights a pathogenic germline variant in the CDH1 gene linked to hereditary diffuse gastric cancer and poorly differentiated gallbladder adenocarcinoma. This suggests a potential carcinogenic relationship between the stomach and gallbladder.